| Name | Walgreens #10377 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 1711 N Morley St, Moberly, Missouri 65270 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (660) 263-0793 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers from the University of Murcia have studied the changes in the brain that are associated with impulsiveness, a personality trait that causes difficulties in inhibiting a response in the face of a stimulus and leads to unplanned actions without considering the negative consequences.
Galectin Therapeutics, the Cancer Centre at the Cliniques universitaires Saint-Luc and the Ludwig Institute for Cancer Research (LICR) announced today that they will initiate a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma.
Illumina, Inc. today announced that its Board of Directors has approved a new stock repurchase program, authorizing the company to repurchase in the aggregate up to $100 million of its outstanding common stock. The $75 million share repurchase program originally announced on August 24, 2009, recently has been completed.
During the next 10 years, an estimated half-million individuals in the U.S. with autism spectrum disorder (ASD) are expected to transition from adolescence to adulthood, according to the Centers for Disease Control and Prevention.
DHA omega-3 innovator and maker of the life'sDHA(TM) brand, Martek Biosciences Corporation (Nasdaq: MATK), announced today it has resolved a patent dispute with Capsugel France. The resolution follows Martek's November 2008 action for infringement filed in the High Court of Strasbourg, France.
› Verified 1 days ago
| NPI Number | 1962562058 |
| Organization Name | WALGREEN CO. |
| Doing Business As | WALGREENS #10377 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1711 N Morley St, Moberly, MO 65270 |
| Phone Number | 660-263-0793 |
News Archive
Researchers from the University of Murcia have studied the changes in the brain that are associated with impulsiveness, a personality trait that causes difficulties in inhibiting a response in the face of a stimulus and leads to unplanned actions without considering the negative consequences.
Galectin Therapeutics, the Cancer Centre at the Cliniques universitaires Saint-Luc and the Ludwig Institute for Cancer Research (LICR) announced today that they will initiate a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma.
Illumina, Inc. today announced that its Board of Directors has approved a new stock repurchase program, authorizing the company to repurchase in the aggregate up to $100 million of its outstanding common stock. The $75 million share repurchase program originally announced on August 24, 2009, recently has been completed.
During the next 10 years, an estimated half-million individuals in the U.S. with autism spectrum disorder (ASD) are expected to transition from adolescence to adulthood, according to the Centers for Disease Control and Prevention.
DHA omega-3 innovator and maker of the life'sDHA(TM) brand, Martek Biosciences Corporation (Nasdaq: MATK), announced today it has resolved a patent dispute with Capsugel France. The resolution follows Martek's November 2008 action for infringement filed in the High Court of Strasbourg, France.
› Verified 1 days ago
News Archive
Researchers from the University of Murcia have studied the changes in the brain that are associated with impulsiveness, a personality trait that causes difficulties in inhibiting a response in the face of a stimulus and leads to unplanned actions without considering the negative consequences.
Galectin Therapeutics, the Cancer Centre at the Cliniques universitaires Saint-Luc and the Ludwig Institute for Cancer Research (LICR) announced today that they will initiate a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma.
Illumina, Inc. today announced that its Board of Directors has approved a new stock repurchase program, authorizing the company to repurchase in the aggregate up to $100 million of its outstanding common stock. The $75 million share repurchase program originally announced on August 24, 2009, recently has been completed.
During the next 10 years, an estimated half-million individuals in the U.S. with autism spectrum disorder (ASD) are expected to transition from adolescence to adulthood, according to the Centers for Disease Control and Prevention.
DHA omega-3 innovator and maker of the life'sDHA(TM) brand, Martek Biosciences Corporation (Nasdaq: MATK), announced today it has resolved a patent dispute with Capsugel France. The resolution follows Martek's November 2008 action for infringement filed in the High Court of Strasbourg, France.
› Verified 1 days ago
Mid Missouri Eye Type: Medicare Supplier Location: 630 N Morley St, Moberly, Missouri 65270 Phone: (660) 263-0404 | |
Kribbs Family Pharmacy Type: Pharmacy Location: 319 W Reed St, Moberly, Missouri 65270 Phone: (660) 263-8020 | |
Community Medical Equipment Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1315 E 24 Hwy Ste E, Moberly, Missouri 65270 Phone: (660) 263-1700 | |
Hils Pharmacy Type: Community/Retail Pharmacy Location: 907 N Morley St, Moberly, Missouri 65270 Phone: (660) 263-4457 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1903 Morley Street, Moberly, Missouri 65270 Phone: (660) 263-1939 |